NET PROFIT (x1000 SEK)
Centrum för Andrologi och Urologi i Sverige AB
Closing information (x1000 SEK)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
0
|
0
|
0 |
| Financial expenses |
0
|
1
|
0 |
| Earnings before taxes |
1,555
|
2,253
|
814 |
| EBITDA |
-21
|
-24
|
-19 |
| Total assets |
8,853
|
8,894
|
8,957 |
| Current assets |
933
|
900
|
762 |
| Current liabilities |
1,320
|
2,111
|
3,675 |
| Equity capital |
7,121
|
6,385
|
4,899 |
| - share capital |
50
|
50
|
50 |
| Employees (average) |
0
|
0
|
0 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
80.4%
|
71.8%
|
54.7% |
| Turnover per employee | |||
| Profit as a percentage of turnover | |||
| Return on assets (ROA) |
17.6%
|
25.3%
|
9.1% |
| Current ratio |
70.7%
|
42.6%
|
20.7% |
| Return on equity (ROE) |
21.8%
|
35.3%
|
16.6% |
| Change turnover |
0
|
0
|
0 |
| Change turnover % | |||
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.